Research benefits for hypothetical HIV vaccine trials: The views of Ugandans in the Rakai district

IRB Ethics and Human Research

Volumn 30, Issue 2, 2008, Pages 1-7

  Grady, Christine ^a   Wagman, Jennifer ^b   Ssekubugu, Robert ^c   Wawer, Maria J ^b   Serwadda, David ^d   Kiddugavu, Mohammed ^c   Nalugoda, Fred ^e   Gray, Ronald H ^b   Wendler, David ^a   Dong, Qian ^f   Dixon, Dennis O ^g   Townsend, Bryan ^h   Wahl, Elizabeth ⁱ   Emanuel, Ezekiel J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

^e RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^f MERCK RESEARCH LABORATORIES   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h YALE UNIVERSITY   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADOLESCENT; ADULT; ATTITUDE; CLINICAL TRIAL; EPIDEMIOLOGY; ETHICS; FEMALE; HUMAN; INTERNATIONAL COOPERATION; MALE; METHODOLOGY; MIDDLE AGED; REVIEW; UGANDA;

ADOLESCENT; ADULT; AIDS VACCINES; ATTITUDE; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH CARE SURVEYS; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; RESEARCH DESIGN; UGANDA;

EID: 42549093944     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Wertheimer A. Exploitation. Princeton, NJ: Princeton University Press, 1996.
2. Macklin R. Double Standards in Medical Research in Developing Countries. Cambridge, UK: Cambridge University Press, 2004;
3. National Bioethics Advisory Commission. Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries. Vol. 1. Bethesda, MD, 2001;
4. Emanuel E, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? Benchmarks of ethical research. Journal of Infectious Diseases 2004;189:930-937.
5. Nuffield Council on Bioethics. The Ethics of Research Related to Healthcare in Developing Countries. 2002. http://www.nuffieldbioethics.org/ go/print/ourwork/devel-opingcountries/introduction;
6. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: CIOMS, 2002. http://www.cioms.ch/frame_guidelines_nov_ 2002.htm;
7. see ref. 2, National Bioethics Advisory Commission 2001, recommendation 1.3;
8. World Medical Association. Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. October 2000. Principle 19. http://www.wma.net/e/pol-icy/b3.htm.
9. See ref. 2, National Bioethics Advisory Commission 2001;
10. Participants in the 2001 Conference on Ethical Aspects of Research in Peveloping Countries. Moral standards for research in developing countries: From "reasonable availability" to "fair benefits." Hastings Center Report 2004;34(3 ):17-27.
11. See ref. 3, CIOMS 2002;
12. see ref. 2, Declaration of Helsinki 2000;
13. UNAIDS. Ethical Considerations in HIV Preventive Vaccine Research. 2000. Guidance Point 10. http://www.who.int/vaccine_research/dis-eases/hiv/en/ JCo72-EthicalCons-E.pdf.
14. See ref. 3, CIOMS 2002, Guideline 7.
15. Celentano DD, Beyrer C, Natpratan C, et al. Willingness to participate in AIDS vaccine trials among high risk populations in northern Thailand. AIDS 1995; 9(9):1079-1083;
16. Jenkins RA, Tougsa K, Markowitz LE, et al. Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections 2000;76(5):386-392.
17. Russell M, Moralejo D, Burgess E. Paying research subjects: Participants' perspectives. Journal of Medical Ethics 2000;26:126-130.
18. See ref. 2, Declaration of Helsinki 2000, Principle 19.
19. See ref. 3, CIOMS 2002, Guideline 10.
20. Glantz LH, Annas GJ, Grodin MA, Mariner WK. Research in developing countries: Taking "benefit" seriously. Hastings Center Report 1998;28(6):38-42;
21. Shapiro H, Meslin E. Ethical issues in the design and conduct of clinical trials in developing countries. NEJM 2001;345:139-142.
22. Nuffield Council on Bioethics. The Ethics of Research Related to Healthcare in Developing Countries: A Follow Up Discussion Paper. 2005. http://www. nuffieldbioethics.org/.
23. See ref. 2, National Bioethics Advisory Commission 2001;
24. See ref. 11, Glantz et al. 1998;
25. Cooley DR. Distributive justice and clinical trials in the third world. Theoretical Medicine 2001;22:151-167;
26. Benatar SR. Review: Distributive justice and clinical trials in the third world. Theoretical Medicine 2001;22:169-176;
27. Lie RK. Justice and international research. In: Levine RJ, Gorowitz S, Gallagher J, eds. Biomedical Research Ethics: Updating International Guidelines. Geneva, Switzerland: CIOMS, 2000, p. 27-40;
28. Benatar SR. Justice and international research: A response to Reidar K. Lie. In: Levine RJ, Gorowitz S, Gallagher J, eds. Biomedical Research Ethics: Updating International Guidelines. Geneva, Switzerland: CIOMS, 2000, p. 41-50.
29. Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries. Fair benefits for research in developing countries. Science 2002;298:2133-2134;
30. see ref. 4, Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries 2004.
31. Thiessen C, Ssekubugu R, Wagman J, et al. Personal and community benefits and harms of research: Views from Rakai, Uganda. AIDS 2O07;21(18):1493-2501.
32. Kiwanuka N, Robb M, Kigozi G, et al. Knowledge about vaccines and willingness to participate in HIV vaccine trials. Journal of the Acquired Immune Deficiency Syndromes. 2004;36(2):721-725.
33. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998;12(10):1211-1125;
34. Wawer MJ, Serwadda D, Gray RH, et al. Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: Data from the Rakai population-based cohort, Uganda. AIDS 1997;11(8):1023-1030;
35. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet 13;353(9152.)=525-535-
36. Numbers add up to more than 100% because some respondents suggested more than one thing.
37. See ref. 3, CIOMS 2002.
38. Widdus R. Public-private partnerships: An overview. Transactions of the Royal Society of Tropical Medicine and Hygiene 2005, 99(supp 1):1-8
39. See ref. 5, UNAIDS 2000.
40. See ref. 15, Kiwanuka et al. 2004.